MiNK Therapeutics, Inc. - Common Stock (INKT)
23.25
+0.14 (0.61%)
NASDAQ · Last Trade: Jul 17th, 5:27 PM EDT
Detailed Quote
Previous Close | 23.11 |
---|---|
Open | 23.98 |
Bid | 23.10 |
Ask | 23.30 |
Day's Range | 23.20 - 30.30 |
52 Week Range | 4.560 - 76.00 |
Volume | 1,854,911 |
Market Cap | 800.31M |
PE Ratio (TTM) | -6.720 |
EPS (TTM) | -3.5 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,645,228 |
Chart
About MiNK Therapeutics, Inc. - Common Stock (INKT)
Mink Therapeutics Inc is a biotechnology company focused on developing innovative therapeutic solutions to address unmet medical needs. The company specializes in creating advanced treatments targeting various diseases and conditions by leveraging cutting-edge technologies in drug discovery and development. With a commitment to enhancing patient outcomes, Mink Therapeutics aims to bring novel therapies from the lab to the clinic, fostering improvements in healthcare through scientific research and collaboration. Read More
News & Press Releases
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · July 17, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · July 15, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · July 15, 2025
Via Benzinga · July 15, 2025
iNKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy
By MiNK Therapeutics · Via GlobeNewswire · July 15, 2025
Via Benzinga · July 15, 2025
Via Benzinga · July 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Unusual volume stocks in Monday's session
Via Chartmill · July 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 11, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · July 11, 2025
Via Benzinga · July 11, 2025
MiNK Therapeutics shares jumped as new clinical data show durable remission in testicular cancer and tumor reduction in gastric cancer using its iNKT cell therapy, agenT-797, in combination with Opdivo.
Via Benzinga · July 11, 2025
Via Benzinga · July 11, 2025
“These findings are part of a growing body of clinical evidence supporting the potential of agenT-797 in solid tumors,” the company said.
Via Stocktwits · July 11, 2025
Via Benzinga · July 11, 2025